News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Samsung Group, Quintiles Transnational Corp. Plan $266 Million Venture to Make Biologic Drugs


2/25/2011 6:48:53 AM

Bloomberg -- Samsung Group, the South Korean company whose businesses range from electronics to ship-building, will partner with Quintiles Transnational Corp. to make biologic drugs as it seeks new businesses to drive growth.

Read at Bloomberg
Read at Washington Post
Read at News Release
Read at Wall Street Journal
Read at News Release


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES